TickerFacts.

A business in context

IBRX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-14 · 0001193125-26-421820 · Items 7.01,9.01

  2. 4 · Ownership change

    Report date 2026-10-05 · 0001326110-26-000085

  3. 4 · Ownership change

    Report date 2026-10-02 · 0001326110-26-000084

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001326110-26-000079

  5. 8-K · Current report

    Report date 2026-08-04 · 0001326110-26-000077 · Items 2.02,9.01

  6. 8-K · Current report

    Report date 2026-07-29 · 0001326110-26-000071 · Items 7.01,9.01

  7. 4 · Ownership change

    Report date 2026-07-01 · 0001849739-26-000014

  8. 4 · Ownership change

    Report date 2026-07-02 · 0001529371-26-000008

  9. 4 · Ownership change

    Report date 2026-06-29 · 0001849739-26-000011

  10. 4 · Ownership change

    Report date 2026-06-24 · 0001647994-26-000011

  11. 4 · Ownership change

    Report date 2026-06-09 · 0001849739-26-000007

  12. 4 · Ownership change

    Report date 2026-06-09 · 0001822674-26-000003

  13. 8-K · Current report

    Report date 2026-06-09 · 0001326110-26-000064 · Items 5.07,9.01

  14. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-229153 · Items 1.01,7.01,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001326110-26-000059

  16. 8-K · Current report

    Report date 2026-05-07 · 0001326110-26-000057 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-09 · 0001326110-26-000049

  18. 8-K · Current report

    Report date 2026-04-09 · 0001326110-26-000036 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-04-06 · 0001193125-26-142932 · Items 7.01,9.01

  20. 8-K · Current report

    Report date 2026-03-30 · 0001193125-26-133363 · Items 1.01,2.03,7.01,8.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001326110-26-000030

  22. 8-K · Current report

    Report date 2026-02-23 · 0001326110-26-000025 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-02-18 · 0001326110-26-000018 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2026-01-23 · 0001326110-26-000014 · Items 1.01,9.01

  25. 8-K · Current report

    Report date 2026-01-15 · 0001326110-26-000008 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2026-01-14 · 0001326110-26-000004 · Items 8.01,9.01

  27. 8-K · Current report

    Report date 2025-12-23 · 0001193125-25-331244 · Items 1.01,8.01,9.01

  28. 8-K · Current report

    Report date 2025-12-10 · 0001326110-25-000146 · Items 5.02,9.01

  29. 8-K · Current report

    Report date 2025-12-12 · 0001326110-25-000143 · Items 8.01,9.01

  30. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001326110-25-000139

  31. 8-K · Current report

    Report date 2025-11-04 · 0001326110-25-000138 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-08-08 · 0001193125-25-177024 · Items 8.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001326110-25-000114

  34. 8-K · Current report

    Report date 2025-08-05 · 0001326110-25-000112 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-07-24 · 0001193125-25-164789 · Items 1.01,2.02,7.01,8.01,9.01

  36. 8-K · Current report

    Report date 2025-06-18 · 0001326110-25-000084 · Items 5.02,5.07,9.01

  37. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001326110-25-000071

  38. 8-K · Current report

    Report date 2025-05-12 · 0001326110-25-000069 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-05-05 · 0001193125-25-112057 · Items 8.01,9.01

  40. DEF 14A · Proxy statement

    Report date 2025-06-18 · 0001326110-25-000054

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 0 transaction rows0AExercise / conversion: 16 transaction rows16MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

20 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-02
2026-07-06
Cohen Cheryl
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock131210.09.5
2026-07-02
2026-07-06
Cohen Cheryl
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock55979.02.98
2026-07-02
2026-07-06
Cohen Cheryl
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
55979.00.0
2026-07-01
2026-07-06
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock35064.02.98
2026-07-01
2026-07-06
Selecky Christobel
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock159478.09.02
2026-07-01
2026-07-06
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock124414.02.99
2026-07-01
2026-07-06
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
124414.00.0
2026-07-01
2026-07-06
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
35064.00.0
2026-06-30
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1000.09.0
2026-06-30
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock300.02.99
2026-06-30
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock700.02.98
2026-06-30
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
300.00.0
2026-06-30
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
700.00.0
2026-06-29
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock32173.02.98
2026-06-29
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock33549.02.99
2026-06-29
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock30000.02.84
2026-06-29
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock95722.09.01
2026-06-29
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
32173.00.0
2026-06-29
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
33549.00.0
2026-06-29
2026-07-01
Selecky Christobel
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
30000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001326110ImmunityBio, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • NantKwest, Inc. · former SEC name · 2015-06-10 to 2021-03-08
  • Conkwest, Inc. · former SEC name · 2014-04-17 to 2015-07-13
  • ZelleRx Corp · former SEC name · 2005-04-29 to 2009-10-09

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$14.74M$15.84M
2023-12-31$622.0K$687.8K
2022-12-31$240.0K$276.3K
2021-12-31$934.0K$1.16M
2020-12-31$605.0K$787.6K
2019-12-31$2.20M$2.90M
2018-12-31$47.0K$63.1K
2017-12-31$45.0K$61.9K

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗